We are live on ! Find out more
Scott Ferguson

Scott Ferguson Sachem Head Capital Management

AUM $3.97B Turnover 39.13%
1-Year Est. Return 45.91%
 

Scott Ferguson is the founder of Sachem Head Capital Management, an activist and fundamental equity firm. He previously worked at firms including Corvex and built a reputation for research-driven campaigns at public companies. Ferguson’s filings and activist situations are followed closely in event-driven and engagement-oriented investing circles.

This Fund
S&P 500
This Quarter Est. Return
+14.04%
1 Year Est. Return
+45.91%
3 Year Est. Return
+176.86%
5 Year Est. Return
+140.12%
10 Year Est. Return
+830.96%
AUM
$1.51B
AUM Growth
+$166M
Cap. Flow
+$17.8M
Cap. Flow %
1.18%
Top 10 Hldgs %
100%
Holding
9
New
2
Increased
–
Reduced
1
Closed
1
Avg Time Held
0.6 years
Top 10 Avg Time Held
0.6 years
Top 20 Avg Time Held
0.6 years

Top Sells

Rank Stock Value
1
DG icon
Dollar General
DG
+$93.7M
2
VTRS icon
Viatris
VTRS
+$29.6M

Sector Composition

Rank Sector Weight
1 Healthcare 39.39%
2 Industrials 39.17%
3 Materials 8.72%
4 Miscellaneous 8.31%
5 Communication Services 4.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
CDK
1
DELISTED
CDK Global
CDK
$591M 39.17%
12,647,333
– –
2014 Q4
1 quarter
AGN
2
DELISTED
Allergan plc
AGN
$238M 15.77%
800,000
– –
2014 Q3
2 quarters
ZTS icon
3
Zoetis
ZTS
$34B
$203M 13.47%
4,395,000
– –
2014 Q1
4 quarters
APD icon
4
Air Products & Chemicals
APD
$69.8B
$132M 8.72%
940,470
– –
2014 Q1
4 quarters
SLXP
5
DELISTED
Salix Pharmaceuticals
SLXP
$125M 8.31%
+725,000
New +$106M
2015 Q1
0 quarters
VTRS icon
6
Viatris
VTRS
$23.6B
$115M 7.64%
1,945,000
-520,000
-21% -$29.6M
2014 Q1
4 quarters
TFCFA
7
DELISTED
Twenty-First Century Fox Class A
TFCFA
$66.7M 4.42%
1,971,762
– –
2014 Q1
4 quarters
BIO icon
8
Bio-Rad Laboratories Class A
BIO
$9.7B
$37.8M 2.51%
+280,000
New +$34.7M
2015 Q1
0 quarters
DG icon
9
Dollar General
DG
$29.8B
– –
-1,325,000
Closed -$93.7M –

Similar funds

Scott Ferguson's Q1 2015 Portfolio in Review

As of Q1 2015, Scott Ferguson held 9 positions worth $1.51B, up 12% from $1.34B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Scott Ferguson's Q1 2015 filing shows 2 new, 1 reduced and 1 closed positions. Its largest new stake was Salix Pharmaceuticals: 725,000 shares worth $125M. The largest sale was Dollar General, an estimated $93.7M.

By sector, the portfolio is most concentrated in Healthcare at 39% of assets, down from 40% a quarter earlier, followed by Industrials and Materials.

  • Scott Ferguson's largest Q1 2015 buy was Salix Pharmaceuticals: 725,000 shares worth $125M.
  • Scott Ferguson's biggest Q1 2015 reduction was Viatris, cutting an estimated $29.6M.
  • Scott Ferguson fully exited Dollar General in Q1 2015, selling an estimated $93.7M.
  • Scott Ferguson's ten largest holdings make up 100% of its $1.51B portfolio in Q1 2015.
  • Scott Ferguson opened 2 new positions and closed 1 in Q1 2015.
  • Scott Ferguson's portfolio value rose 12% quarter-over-quarter to $1.51B.

Based on Sachem Head Capital Management's 13F filing for Q1 2015, filed 15 May 2015.